Skip to main content

Antimicrobial Resistance (AMR)


Global regulators support World Antimicrobial Awareness Week 2021

To mark World Antimicrobial Awareness Week in 2021, ICMRA has developed a set of info-cards to raise awareness of the growing public health problem of antimicrobial resistance (AMR) and the need to address it. The info-cards call on global health leaders, healthcare professionals and patients to take action.

ICMRA encourages stakeholders to join the fight against AMR and share the recommendations with others.

The latest set of info-cards builds on the success of the campaign launched during World Antimicrobial Awareness Week in 2020.


Other languages


Global regulators support World Antimicrobial Awareness Week 2020

In support of the World Antimicrobial Awareness Week 2020, which is marked from 18 to 24 November 2020, the International Coalition of Medicines Regulatory Authorities (ICMRA) has published a set of info-cards. The info-cards stress the need for cross-sectoral, global cooperation to combat antimicrobial resistance around the world and highlight the important role of global health leaders, medicines regulators, researchers, pharmaceutical industry and media.
World Antimicrobial Awareness Week aims to raise awareness of the growing public health threat of antimicrobial resistance and to promote best practices among policy makers, healthcare professionals and the general public to avoid the emergence and spread of multidrug-resistant bacterial infections.
‘The problem of antimicrobial resistance is multifaceted and cannot be addressed by one single organisation or sector. A coordinated global approach and commitment are required to tackle this public health threat,’ said Emer Cooke, Chair of ICMRA and EMA’s Executive Director. ’As global regulators, we have a responsibility to bring to the market safe, effective and high-quality medicines that can help combat antimicrobial resistance. International collaboration is crucial to streamline regulatory requirements and facilitate access to critical antimicrobials around the world.’
Since 2019, ICMRA has convened several panel discussions with international regulators and other key stakeholders to provide strategic direction and find innovative solutions to fight the spread of antimicrobial resistance. As a result, ICMRA published a joint statement on antimicrobial resistance aimed to reinforce national commitment and stimulate global action to address this public health threat. The statement is available in multiple languages.